Effects of Transforming Growth Factor-β1 on Parathyroid Hormone-Related Protein mRNA Expression and Protein Secretion in Canine Prostate Epithelial, Stromal, and Carcinoma Cells

Prostate

Volumn 58, Issue 4, 2004, Pages 366-373

  Sellers, Rani S ^a   LeRoy, Bruce E ^a   Blomme, Eric A G ^a   Tannehill Gregg, Sarah ^a   Corn, Stephanie ^a   Rosol, Thomas J ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Department of Veterinary Biosciences ^*  (United States)

Author keywords

Animal model; Dog; Parathyroid hormone related protein; Prostate; Prostate cancer; Transforming growth factor beta

Indexed keywords

ARGININE ESTERASE; MESSENGER RNA; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; ARTICLE; BONE METASTASIS; CARCINOMA CELL; CONTROLLED STUDY; IMMUNORADIOMETRIC ASSAY; MALE; NONHUMAN; NORTHERN BLOTTING; OSTEOBLAST; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROTEIN SECRETION; STROMA CELL;

ANIMALS; DOGS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; MALE; PARATHYROID HORMONE-RELATED PROTEIN; PROSTATE; PROSTATIC NEOPLASMS; RNA, MESSENGER; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 1542377526     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20029     Document Type: Article

References (39)

1. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics 1994. CA Cancer J Clin 1994;44:7-26.
2. Harada M, Iida M, Yamaguchi M, Shida K. Analysis of bone metastasis of prostatic adenocarcinomas in 137 autopsy cases. Adv Exp Med Biol 1992;324:173-182.
3. Yoneda T. Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 1998;34:240-245.
4. Rosol TJ, Tannehill-Gregg SH, LeRoy BE, Mandl S, Contag CH. Animal models of bone metastasis. Cancer 2003;97:748-757.
5. Story MT, Hopp KA, Molter M. Expression of transforming growth factor beta 1 (TGF beta 1), -beta 2, and -beta 3 by cultured human prostate cells. J Cell Physiol 1996;169:97-107.
6. Lee C, Sintich SM, Mathews EP, Shah AH, Kundu SD, Perry KT, Cho JS, Ilio KY, Cronauer MV, Janulis L, Sensibar JA. Transforming growth factor-beta in benign and malignant prostate. Prostate 1999;39:285-290.
7. Perry KT, Anthony CT, Steiner MS. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in normal and malignant human prostate. Prostate 1997;33:133-140.
8. Pfeilschifter J, Diel I, Scheppach B, Bretz A, Krempien R, Erdmann J, Schmid G, Reske N, Bismar H, Seck T, Krempien B, Ziegler R. Concentration of transforming growth factor beta in human bone tissue: Relationship to age, menopause, bone turnover, and bone volume. J Bone Miner Res 1998;13:716-730.
9. Fenton AJ, Kemp BE, Kent GN, Moseley JM, Zheng M-H, Rowe DJ, Britto JM, Martin TJ, Nicholson GC. A carboxy-terminal peptide from the parathyroid hormone-related protein inhibits bone resorption by osteoclasts. Endocrinology 1991;129:1762-1768.
10. Zheng MH, McCaughan HB, Papadimitriou JM, Nicholson GC, Wood DJ. Tartrate resistant acid phosphatase activity in rat cultured osteoclasts is inhibited by a carboxyl terminal peptide (osteostatin) from parathyroid hormone-related protein. J Cell Biochem 1994;54:145-153.
11. Zheng MH, Wood DJ, Papadimitriou JM. What's new in the role of cytokines on osteoblast proliferation and differentiation? Pathol Res Pract 1992;188:1104-1121.
12. Aquilina JW, McKinney L, Pacelli A, Richman LK, Waters DJ, Thompson I, Burghardt WF Jr., Bostwick DG. High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancer. Prostate 1998;36:189-193.
13. Blomme EA, Sugimoto Y, McCauley LK, Lin YC, Capen CC, Rosol TJ. Stromal and epithelial cells of the canine prostate express parathyroid hormone-related protein, but not the PTH/ PTHrP receptor. Prostate 1998;36:110-120.
14. Ding VD, Moller DE, Feeney WP, Didolkar V, Nakhla AM, Rhodes L, Rosner W, Smith RG. Sex hormone-binding globulin mediates prostate androgen receptor action via a novel signaling pathway. Endocrinology 1998;139:213-218.
15. Gotham SM, Fryer PJ, Paterson WR. The measurement of insoluble proteins using a modified Bradford assay. Anal Biochem 1988;173:353-358.
16. LeRoy BE, Bahnson RR, Rosol TJ. Canine prostate induces new bone formation in mouse calvaria: A model of osteoinduction by prostate tissue. Mol Cell Endocrinol 2002;197:257-263.
17. Werkmeister JR, Blomme EA, Weckmann MT, Grone A, McCauley LK, Wade AB, O'Rourke J, Capen CC, Rosol TJ. Effect of transforming growth factor-beta1 on parathyroid hormone-related protein secretion and mRNA expression by normal human keratinocytes in vitro. Endocrine 1998;8:291-299.
18. Merryman JI, DeWille JW, Werkmeister JR, Capen CC, Rosol TJ. Effects of transforming growth factor-beta on parathyroid hormone-related protein production and ribonucleic acid expression by a squamous carcinoma cell line in vitro. Endocrinology 1994;134:2424-2430.
19. Wysolmerski JJ, McCaughern-Carucci JF, Daifotis AG, Broadus AE, Philbrick WM. Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development 1995;121:3539-3547.
20. Wysolmerski JJ, Stewart AF. The physiology of parathyroid hormone-related protein: An emerging role as a developmental factor. Annu Rev Physiol 1998;60:431-460.
21. Broadus AE, Stewart AF. The parathyroids. New York: Raven Press, Ltd; 259 p.
22. Goltzman D, Karaplis AC, Kremer R, Rabbani SA. Molecular basis of the spectrum of skeletal complications of neoplasia. Cancer 2000;88:2903-2908.
23. Rabbani SA, Gladu J, Harakidas P, Jamison B, Goltzman D. Overproduction of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo. Int J Cancer 1999;80:257-264.
24. Sugihara A, Maeda O, Tsuji M, Tsujimura T, Nakata Y, Akedo H, Kotake T, Terada N. Expression of cytokines enhancing the osteoclast activity, and parathyroid hormone-related protein in prostatic cancers before and after endocrine therapy: An immunohistochemical study. Oncol Rep 1998;5:1389-1394.
25. Guise TA, Mundy GR. Cancer and bone. Endocr Rev 1998;19:18-54.
26. Dube JY, Lazure C, Tremblay RR. Dog prostate arginine esterase is related to human prostate specific antigen. Clin Invest Med 1986;9:51-54.
27. Bourassa C, Nguyen LT, Roberts KD, Chevalier S. Characterization of protein-tyrosine kinase activity in the canine prostate. Biochem Cell Biol 1991;69:146-153.
28. Chapdelaine P, Gauthier E, Ho-Kim MA, Bissonnette L, Tremblay RR, Dube JY. Characterization and expression of the prostatic arginine esterase gene, a canine glandular kallikrein. DNA Cell Biol 1991;10:49-59.
29. Cramer SD, Chen Z, Peehl DM. Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: Inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts. J Urol 1996;156:526-531.
30. Iwamura M, Hellman J, Cockett AT, Lilja H, Gershagen S. Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen. Urology 1996;48:317-325.
31. Fenton AJ, Kemp BE, Hammonds RG Jr, Michelhill K, Moseley JM, Martin TJ, Nicholson GC. A potent inhibitor of osteoclastic bone resorption within a highly conserved peptapeptide region of parathyroid hormone-related protein: PTHrP[107-111]. Endocrinology 1991;129:3424-3426.
32. Glynne-Jones E, Harper ME, Goddard L, Eaton CL, Matthews PN, Griffiths K. Transforming growth factor beta 1 expression in benign and malignant prostatic tumors. Prostate 1994;25:210-218.
33. Barrack ER. TGF beta in prostate cancer: A growth inhibitor that can enhance tumorigenicity. Prostate 1997;31:61-70.
34. Wikstrom P, Stattin P, Franck-Lissbrant I, Damber JE, Bergh A. Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer. Prostate 1998;37:19-29.
35. Gold LI. The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncog 1999;10:303-360.
36. Wu G, Iwamura M, di Sant'Agnese PA, Deftos LJ, Cockett AT, Gershagen S. Characterization of the cell-specific expression of parathyroid hormone-related protein in normal and neoplastic prostate tissue. Urology 1998;51:110-120.
37. Dougherty KM, Blomme EA, Koh AJ, Henderson JE, Pienta KJ, Rosol TJ, McCauley LK. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma. Cancer Res 1999;59:6015-6022.
38. Waters DJ, Bostwick DG. The canine prostate is a spontaneous model of intraepithelial neoplasia and prostate cancer progression. Anticancer Res 1997;17:1467-1470.
39. Waters DJ, Hayden DW, Bell FW, Klausner JS, Qian J, Bostwick DG. Prostatic intraepithelial neoplasia in dogs with spontaneous prostate cancer. Prostate 1997;30:92-97.